132 related articles for article (PubMed ID: 6106782)
21. Control of pancreatic polypeptide secretion by glucose in man.
Marco J; Hedo JA; Villanueva ML
J Clin Endocrinol Metab; 1978 Jan; 46(1):140-5. PubMed ID: 752016
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients.
Del Prato S; Riccio A; Vigili de Kreutzenberg S; Dorella M; Avogaro A; Marescotti MC; Tiengo A
Metabolism; 1993 Jan; 42(1):24-9. PubMed ID: 8446044
[TBL] [Abstract][Full Text] [Related]
23. [Insulin assay in insulinoma].
Zeng XJ
Zhonghua Wai Ke Za Zhi; 1984 Jan; 22(1):13-8, 62. PubMed ID: 6097422
[No Abstract] [Full Text] [Related]
24. Stimulation of pancreatic polypeptide and glucagon secretion by 2-deoxy-D-glucose in man: evidence for cholinergic mediation.
Hedo JA; Villanueva ML; Marco J
J Clin Endocrinol Metab; 1978 Aug; 47(2):366-71. PubMed ID: 400718
[TBL] [Abstract][Full Text] [Related]
25. Influence of a transplantable insulinoma on the pancreatic status of insulin and pancreatic polypeptide in the rat.
O'Hare MM; Shaw C; Swanston-Flatt SK; Marcelli M; Buchanan KD; Flatt PR
Diabetologia; 1985 Mar; 28(3):157-60. PubMed ID: 2987070
[TBL] [Abstract][Full Text] [Related]
26. Control of basal insulin secretion, with special reference to the diagnosis of insulinomas.
Turner RC; Oakley NW; Nabarro JD
Br Med J; 1971 Apr; 2(5754):132-5. PubMed ID: 4325738
[TBL] [Abstract][Full Text] [Related]
27. Immunoreactive insulin assay in insulinoma.
Zeng XJ; Yao CZ; Zhong SX; Zhang JX; Zhu Y; Wu CY
Chin Med J (Engl); 1983 Aug; 96(8):575-82. PubMed ID: 6315315
[No Abstract] [Full Text] [Related]
28. Lack of diabetogenic action of calcitonin in subjects affected by insulinoma.
Passariello N; Paolisso G; Iannuzzi F; Pizza G; Marrazzo G; Sgambato S; D'Onofrio F
Diabete Metab; 1989; 15(2):88-92. PubMed ID: 2544469
[TBL] [Abstract][Full Text] [Related]
29. [Differential diagnosis of tumor-associated hypoglycemia--exemplified by an insulinoma and a hemangiopericytoma. Case reports and review of the literature].
Ollenschläger G; Steinmetz T; Hoffmann A; Fischer H; Schindler J; Allolio B
Med Klin (Munich); 1988 May; 83(12):391-7, 428. PubMed ID: 2841561
[No Abstract] [Full Text] [Related]
30. [A case of insulinoma].
Deliège M; Jardon-Jeghers C
Acta Clin Belg; 1980; 35(5):306-13. PubMed ID: 6261504
[No Abstract] [Full Text] [Related]
31. The clinical diagnosis of insulinoma.
Seyer-Hansen K; Lundbaek K
Scand J Gastroenterol Suppl; 1979; 53():39-42. PubMed ID: 225785
[TBL] [Abstract][Full Text] [Related]
32. Insulinoma: clinical manifestations, diagnosis and treatment. The significance of the prolonged fasting test and of the fasting blood glucose-insulin relationship.
Johansen K
J Endocrinol Invest; 1979; 2(3):285-90. PubMed ID: 231064
[TBL] [Abstract][Full Text] [Related]
33. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
[TBL] [Abstract][Full Text] [Related]
34. Effect of age on fasting plasma levels of pancreatic hormones in man.
Berger D; Crowther RC; Floyd JC; Pek S; Fajans SS
J Clin Endocrinol Metab; 1978 Dec; 47(6):1183-9. PubMed ID: 400740
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic interpretation of the intravenous tolbutamide test for insulinoma.
McMahon MM; O'Brien PC; Service FJ
Mayo Clin Proc; 1989 Dec; 64(12):1481-8. PubMed ID: 2557494
[TBL] [Abstract][Full Text] [Related]
36. Editorial: Diagnosis of insulinoma.
Lancet; 1974 Aug; 2(7877):385-6. PubMed ID: 4136659
[No Abstract] [Full Text] [Related]
37. Diurnal profile of plasma motilin concentrations during fasting and feeding in man.
Funakoshi A; Ho LL; Jen KL; Knopf R; Vinik AI
Gastroenterol Jpn; 1985 Oct; 20(5):446-56. PubMed ID: 3908210
[TBL] [Abstract][Full Text] [Related]
38. C-peptide suppression test for insulinoma.
Service FJ; Horwitz DL; Rubenstein AH; Kuzuya H; Mako ME; Reynolds C; Molnar GD
J Lab Clin Med; 1977 Jul; 90(1):180-6. PubMed ID: 194989
[TBL] [Abstract][Full Text] [Related]
39. Twenty-four-hour variations of plasma pancreatic polypeptide, insulin and glucagon in normal human subjects.
Tasaka Y; Inoue S; Maruno K; Hirata Y
Endocrinol Jpn; 1980 Aug; 27(4):495-8. PubMed ID: 7007033
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the pancreatic polypeptide response to hypoglycemia in man.
Zulueta MA; Vincent E; Correas I; Villanueva ML; Felíu JE; Marco J
Diabete Metab; 1982 Mar; 8(1):47-51. PubMed ID: 7047252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
